Skip to main content

Table 3 Hemorrhagic adverse events

From: A double-blind, randomized, multicenter phase 2 study of prasugrel versus placebo in adult patients with sickle cell disease

Treatment Patient Preferred term Severity Possibly related to study drug
Placebo 1 Hematochezia Mild  
   Gingival bleeding Moderate Yes
   Hemorrhoids Mild  
Prasugrel 2 Menorrhagia Moderate Yes
  3 Menorrhagia Mild Yes
   Ecchymosis Mild  
  4 Epistaxis Mild Yes
  5 Contusion Mild Yes
  6 Epistaxis Mild  
  7 Gingival bleeding Mild Yes
  8 Gingival bleeding Mild Yes
  9 Hematochezia Mild